Ticker League

EBITDA for Intuitive Surgical (ISRG)

Latest filings through · Reported

Metric

TTM

$4.12B

YoY change

+27.2%

5Y CAGR

+24.6%

Peak year (2025)

$3.99B

EBITDA history chart for Intuitive Surgical (ISRG) from 1998 to 2025

Latest: $3.99B

EBITDA growth chart for Intuitive Surgical (ISRG) from 1998 to 2025

Latest: +27.2%

EBITDA history table for Intuitive Surgical (ISRG) from 1998 to 2025

  • 2025$3.99B+27.2%
  • 2024$3.14B+32.8%
  • 2023$2.36B+19.7%
  • 2022$1.97B-10.6%
  • 2021$2.21B+66.5%
  • 2020$1.33B-15.9%
  • 2019$1.58B+19.3%
  • 2018$1.32B+14.2%
  • 2017$1.16B+10.2%
  • 2016$1.05B+26.7%
  • 2015$829.50M+33.1%
  • 2014$623.40M-32.2%
  • 2013$919.80M-1.7%
  • 2012$935.90M+26.3%
  • 2011$741.30M+24.5%
  • 2010$595.60M+44.6%
  • 2009$412.00M+22.6%
  • 2008$335.92M+52.9%
  • 2007$219.77M+54.1%
  • 2006$142.62M+88.9%
  • 2005$75.50M+166.8%
  • 2004$28.30M-2361.8%
  • 2003−$1.25M-92.0%
  • 2002−$15.67M-0.0%
  • 2001−$15.67M-10.6%
  • 2000−$17.52M+1.3%
  • 1999−$17.31M-43.8%
  • 1998−$30.77M—

EBITDA values are taken from Intuitive Surgical's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Intuitive Surgical (ISRG)

According to Intuitive Surgical's latest reported financial statements, the company's current EBITDA (TTM) is $4.12B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

In 2025, Intuitive Surgical (ISRG) EBITDA totalled $3.99B – grew 27.2% year-over-year.

Over 2020–2025 (5 years), Intuitive Surgical EBITDA expanded at a +24.6% compound annual rate, sustaining 3 straight years of year-over-year growth.

The highest annual EBITDA of $3.99B was reported in 2025. The lowest in the available history was −$30.77M in 1998.

Intuitive Surgical EBITDA by Year

Intuitive Surgical EBITDA 2025: $3.99B

2025's EBITDA for Intuitive Surgical came in at $3.99B, grew 27.2% from 2024. This figure represents the highest annual value in the available history.

Intuitive Surgical EBITDA 2024: $3.14B

Intuitive Surgical posted EBITDA of $3.14B in 2024, surged 32.8% from 2023.

Intuitive Surgical EBITDA 2023: $2.36B

In 2023, Intuitive Surgical reported EBITDA of $2.36B, grew 19.7% from 2022.

Intuitive Surgical EBITDA 2022: $1.97B

Intuitive Surgical EBITDA in 2022 was $1.97B, declined 10.6% below 2021.

Intuitive Surgical EBITDA 2021: $2.21B

Intuitive Surgical EBITDA in 2021 was $2.21B.

See more financial history for Intuitive Surgical (ISRG).

Sector peers by EBITDA

Healthcare peers of Intuitive Surgical (ISRG), ranked by their latest EBITDA

Frequently asked questions

Intuitive Surgical (ISRG) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation